For Rivastigmine Capsules & Felodipine Extended - Release Tablets
Orchid Chemicals & Pharmaceuticals announced that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in 1.5 mg, 3 mg, 4.5 mg, 6 mg and Felodipine Extended - Release Tablets in 2.5 mg, 5 mg, 10 mg.Powered by Capital Market - Live News
